English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech HealthCare & Pharma
Novotech稱,聯邦預算研發稅收扶持使澳大利亞在高質量臨床試驗方面具有全球競爭力
May 18, 2018 12:00 HKT
Novotech称,联邦预算研发税收扶持使澳大利亚在高质量临床试验方面具有全球竞争力
May 18, 2018 12:00 HKT
Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials
May 18, 2018 02:00 HKT
HKBU develops world-first metal-based probes for detection of dopamine receptors, a cancer biomarker
May 16, 2018 10:00 HKT
Czech Republic Showcased as Medical Devices Innovator
May 14, 2018 15:30 HKT
Hong Kong International Medical Devices and Supplies Fair Concludes
May 09, 2018 19:00 HKT
Helsinn Group announces the launch of the IV formulation of AKYNZEO(R) (fosnetupitant/palonosetron) in the United States
May 09, 2018 09:00 HKT
Largest-ever HKTDC Hong Kong International Medical Fair Opens
May 07, 2018 18:00 HKT
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers
May 04, 2018 09:00 HKT
Hong Kong International Medical Devices and Supplies Fair Opens Monday
May 03, 2018 18:00 HKT
阿澤雷斯在全公司啟動責任關懷(CSR)計劃
Apr 26, 2018 17:00 HKT
阿泽雷斯在全公司启动责任关怀(CSR)计划
Apr 26, 2018 17:00 HKT
Azelis launches company-wide Corporate Social Responsibility (CSR) programme
Apr 26, 2018 17:00 HKT
平安好医生(01833)的对标对象:远程医疗界的华为
Apr 24, 2018 10:33 HKT
平安好醫生(01833)的對標對象:遠程醫療界的華為
Apr 24, 2018 10:31 HKT
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Apr 20, 2018 22:10 HKT
泰凌医药与美国生物科研PFENEX公司建立战略伙伴关系
Apr 19, 2018 14:31 HKT
泰凌醫藥與美國生物科研PFENEX公司建立戰略夥伴關係
Apr 19, 2018 14:29 HKT
LEH PHARMA LTD.: Company Update
Apr 18, 2018 20:30 HKT
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018
Apr 18, 2018 20:00 HKT
Next >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: